ALX Oncology (NASDAQ:ALXO) Upgraded at Jefferies Financial Group
ALX Oncology (NASDAQ:ALXO – Get Free Report) was upgraded by analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released on Thursday, Marketbeat.com reports. The brokerage currently has a $3.00 target price on the stock, up from their prior target price of $2.00. Jefferies Financial Group’s price objective […]
ALX Oncology (NASDAQ:ALXO – Get Free Report) was upgraded by analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released on Thursday, Marketbeat.com reports. The brokerage currently has a $3.00 target price on the stock, up from their prior target price of $2.00. Jefferies Financial Group’s price objective […]
